The Virtual Clinics
NEET-PG HIGH-YIELD MODULE
CHRONIC PANCREATITIS
All Aetiologies · Pathophysiology · Diagnosis · Management · High-Yield MCQs
Author: Dr. Sharad Maheshwari, MD
imagingsimplified@gmail.com1. Clinical Hook — The Examiner's Vignettes
Chronic pancreatitis (CP) is an irreversible, progressive fibro-inflammatory disease of the pancreas leading to permanent loss of both exocrine and endocrine function. Unlike acute pancreatitis, it is defined by chronicity, structural destruction, and functional consequences — not by a single inflammatory episode.
⚠ THREE CLASSIC VIGNETTE PATTERNS — SPOT THEM INSTANTLY
- Pattern A: 45-yr male, chronic heavy drinker, recurrent epigastric pain for 3 years, now with pale fatty stools and 10 kg weight loss ➔ CP with exocrine insufficiency.
- Pattern B: 35-yr female, no alcohol, recurrent AP since age 22, autoimmune markers positive, IgG4 elevated ➔ Autoimmune Pancreatitis Type 1 (AIP-1, IgG4-RD).
- Pattern C: 28-yr male, cystic fibrosis diagnosed in childhood, progressive steatorrhoea and diabetes ➔ CFTR-related CP with combined exocrine + endocrine failure.
- Pattern D: 60-yr male, no alcohol or gallstones, weight loss, new-onset diabetes, pain, dilated duct on CT ➔ EXCLUDE PANCREATIC CANCER before labelling as idiopathic CP.
2. Epidemiology
Global incidence of CP is 5–12 per 100,000/year; prevalence 50/100,000. Incidence is rising in Asia, partly attributed to changing alcohol patterns and improved diagnosis. Male predominance (3:1) driven primarily by alcohol aetiology. Tropical pancreatitis — common in South and Southeast Asia — makes this topic especially relevant for NEET-PG candidates.
| Parameter | Data |
|---|---|
| Global incidence | 5–12 per 100,000/year (Yadav & Lowenfels, Gastroenterology 2013) |
| Prevalence | ~50 per 100,000 (higher in autopsy studies) |
| Male : Female | 3:1 overall; 1:1 in autoimmune and hereditary subtypes |
| Peak age (alcohol) | 35–50 years |
| Peak age (hereditary) | <20 years (PRSS1 mutations manifest in childhood) |
| Tropical pancreatitis | Highest prevalence in Kerala, Karnataka, Bangladesh — unique phenotype |
| Mortality | Standardised mortality ratio 3.6× vs. general population |
3. Aetiology — TIGAR-O Classification (Memorise for NEET-PG)
TIGAR-O = Toxic-metabolic | Idiopathic | Genetic | Autoimmune | Recurrent acute / severe AP | Obstructive. This is the universally accepted aetiological classification.
| TIGAR-O Category | Aetiology | Key Exam Facts |
|---|---|---|
| T — Toxic-Metabolic | Alcohol (most common, 60–70%) Tobacco (independent risk factor) Hypercalcaemia Hypertriglyceridaemia Chronic renal failure |
Alcohol requires >5–10 yr heavy use. Tobacco doubles CP risk independently. Hypercalcaemia activates trypsinogen directly. |
| I — Idiopathic | Early-onset (<35 yr): tropical overlap Late-onset (>55 yr): pain-free, exocrine failure |
'Tropical pancreatitis' classified here. Late-onset often presents with exocrine failure and PDAC risk — exclude cancer. |
| G — Genetic | PRSS1 (gain-of-function) SPINK1 (loss-of-function modifier) CFTR |
PRSS1: autosomal dominant, 40% lifetime PDAC risk. SPINK1: disease modifier. Genetic testing indicated if <35 yr or family history. |
| A — Autoimmune | Type 1 (AIP-1): IgG4-related, systemic Type 2 (AIP-2): IBD-associated |
AIP-1: elderly men, IgG4 >135 mg/dL. AIP-2: younger, IBD linked. Both respond dramatically to steroids. |
| R — Recurrent AP | Post-necrotising pancreatitis | Sentinel AP event ➔ duct disruption ➔ periductal fibrosis. |
| O — Obstructive | Pancreatic divisum Sphincter of Oddi dysfunction Strictures / Tumour |
Divisum = most common congenital ductal anomaly. Causes disease only with minor papilla stenosis. |
🎯 TROPICAL PANCREATITIS — HIGH-YIELD FOR NEET-PG
- Age of onset: typically 10–30 years. Occurs in lean, malnourished young patients — no alcohol.
- Triad: abdominal pain in childhood + steatorrhoea + diabetes (Type 3c) in young adults.
- Pathognomonic imaging: large intraductal calculi on plain X-ray (visible without contrast).
- Genetics: SPINK1 N34S mutation found in 25–30% of tropical pancreatitis in India.
- Cancer risk: Up to 100× higher risk of PDAC compared to general population.
4. Pathophysiology
Regardless of aetiology, CP converges on a common downstream process: sustained pancreatic stellate cell (PSC) activation driving progressive fibrosis, driven centrally by TGF-β1.
😈 DEVIL'S ADVOCATE — IS CP ALWAYS IRREVERSIBLE?
Classic teaching states CP fibrosis is irreversible. However, Autoimmune Pancreatitis (AIP) can show DRAMATIC reversal of imaging findings with corticosteroid therapy. Examiner's point: If a vignette shows dramatic improvement after steroids ➔ AIP, not alcoholic CP.
5. Clinical Features & Exocrine Reserve
| Feature | Detail & Exam Pearls |
|---|---|
| Pain | Recurrent epigastric pain radiating to back. Relieved by leaning forward. May DECREASE in later disease ('burns out'). |
| Steatorrhoea | Pale, greasy, floating stools. Occurs when lipase output <10% of normal. Late sign. |
| Type 3c Diabetes | Pancreatogenic diabetes: insulin + glucagon deficiency = brittle DM. Absent C-peptide. |
🔬 KEY PHYSIOLOGICAL CONCEPT: EXOCRINE RESERVE
Steatorrhoea appears only when >90% of exocrine function is lost. Therefore, D-xylose absorption test is NORMAL in CP (mucosa is intact). Early serum lipase/amylase may be NORMAL or LOW due to exhausted acinar cell mass. Do not use normal enzymes to rule out late-stage CP.
6. Diagnosis & Imaging Modalities
| Modality | Role & Key Findings |
|---|---|
| Serum IgG4 | >135 mg/dL supports AIP-1 diagnosis. Trap: mildly elevated in ~10% of PDAC. |
| Faecal Elastase-1 | <100 µg/g = severe exocrine insufficiency. Preferred non-invasive functional test. |
| Plain X-ray | Detects calcifications (pathognomonic). Often first abnormality found. |
| MRCP (± Secretin) | Best non-invasive ductal imaging. Secretin-stimulated MRCP is most sensitive for early CP. Shows 'chain of lakes'. |
| EUS | Most sensitive overall for early CP (Rosemont criteria). |
7. Type 3c Pancreatogenic Diabetes
⚠ EXAM TRAP: SULPHONYLUREAS IN CP DIABETES
Sulphonylureas are STRICTLY CONTRAINDICATED in Type 3c diabetes. Because α-cells are also lost, there is no glucagon to counter sulphonylurea-induced hypoglycaemia, resulting in severe, life-threatening hypoglycaemic shock.
8. Structural & Vascular Complications
| Complication | Mechanism & Key Exam Facts |
|---|---|
| Splenic vein thrombosis | Peri-pancreatic inflammation thromboses splenic vein ➔ left-sided (sinistral) portal hypertension ➔ isolated gastric varices. Splenectomy is curative. |
| Splenic pseudoaneurysm | Elastase erosion of vessel wall — lethal haemorrhage. CT angio + embolisation = first-line. |
| Pancreatic pleural fistula | Left-sided pleural effusion with very high amylase (>1,000 U/L). Bridge via ERCP stenting. |
9. Management & Surgery
- Medical: Abstinence from alcohol/tobacco. PERT (with meals + PPI). Insulin for DM.
- Frey procedure: Local resection of head + lateral pancreaticojejunostomy. Best for large duct disease (>5 mm) with head pathology.
- Puestow procedure: Large dilated duct (>7 mm) without head disease; Roux-en-Y drainage.
- Whipple's: Inflammatory head mass that cannot exclude PDAC.
- Total pancreatectomy + IAT: Refractory pain; familial/hereditary CP. Islet autotransplantation prevents severe DM.
🧠 High-Yield Active Recall
Click on the cards to flip them. Rapid-fire revision for NEET-PG one-liners.
💊 PERT Dosage Calculator
Calculate the estimated daily Lipase requirement for a patient with established Exocrine Pancreatic Insufficiency (EPI).
📝 NEET-PG Mastery Quiz
Test your diagnostic and management acumen with 14 clinical vignettes.
Authentic References
- Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001.
- Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013.
- Löhr JM, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). UEG Journal. 2017.
- Chandak GR, et al. Mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) rather than PRSS1 are associated with tropical calcific pancreatitis. J Med Genet. 2002.
- Hart PA, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016.
The Virtual Clinics | Dr. Sharad Maheshwari MD
This module is for educational and board-preparation purposes only.
Comments
Post a Comment